This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, E.
Right arrow Articles by Walsh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, E.
Right arrow Articles by Walsh, K.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Jun 1995, 3415-3423, Vol 15, No. 6
Copyright © 1995, American Society for Microbiology

Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation

E Suzuki, K Guo, M Kolman, YT Yu and K Walsh
Division of Cardiovascular Research, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA.

Vascular smooth muscle cells (VSMCs) reversibly coordinate the expression of VSMC-specific genes and the genes required for cell cycle progression. Here we demonstrate that isoforms of the MEF2/RSRF transcription factor are expressed in VSMCs and in vascular tissue. The MEF2A DNA-binding activity was upregulated when quiescent VSMCs were stimulated to proliferate with serum mitogens. The serum-induction of MEF2A DNA-binding activity occurred approximately 4 h following serum activation, and this correlated with an increase in the level of MEF2A protein without changes in the level of MEF2A mRNA or protein stability. These results indicate that MEF2A induction by serum is regulated at the level of translation.


This article has been cited by other articles:

  • Schnoes, K. K., Jaffe, I. Z., Iyer, L., Dabreo, A., Aronovitz, M., Newfell, B., Hansen, U., Rosano, G., Mendelsohn, M. E. (2008). Research Resource: Rapid Recruitment of Temporally Distinct Vascular Gene Sets by Estrogen. Mol. Endocrinol. 22: 2544-2556 [Abstract] [Full Text]  
  • Satoh, K., Ohnishi, J., Sato, A., Takeyama, M., Iemura, S.-i., Natsume, T., Shibuya, H. (2007). Nemo-Like Kinase-Myocyte Enhancer Factor 2A Signaling Regulates Anterior Formation in Xenopus Development. Mol. Cell. Biol. 27: 7623-7630 [Abstract] [Full Text]  
  • Toro, R., Saadi, I., Kuburas, A., Nemer, M., Russo, A. F. (2004). Cell-specific Activation of the Atrial Natriuretic Factor Promoter by PITX2 and MEF2A. J. Biol. Chem. 279: 52087-52094 [Abstract] [Full Text]  
  • Suzuki, E., Satonaka, H., Nishimatsu, H., Oba, S., Takeda, R., Omata, M., Fujita, T., Nagai, R., Hirata, Y. (2004). Myocyte Enhancer Factor 2 Mediates Vascular Inflammation via the p38-Dependent Pathway. Circ. Res. 95: 42-49 [Abstract] [Full Text]  
  • Suzuki, E., Nishimatsu, H., Satonaka, H., Walsh, K., Goto, A., Omata, M., Fujita, T., Nagai, R., Hirata, Y. (2002). Angiotensin II Induces Myocyte Enhancer Factor 2- and Calcineurin/Nuclear Factor of Activated T Cell-Dependent Transcriptional Activation in Vascular Myocytes. Circ. Res. 90: 1004-1011 [Abstract] [Full Text]  
  • Gorski, D. H., Walsh, K. (2000). The Role of Homeobox Genes in Vascular Remodeling and Angiogenesis. Circ. Res. 87: 865-872 [Abstract] [Full Text]  
  • Belaguli, N. S., Zhou, W., Trinh, T.-H. T., Majesky, M. W., Schwartz, R. J. (1999). Dominant Negative Murine Serum Response Factor: Alternative Splicing within the Activation Domain Inhibits Transactivation of Serum Response Factor Binding Targets. Mol. Cell. Biol. 19: 4582-4591 [Abstract] [Full Text]  
  • Lavie, J., Dandre, F., Louis, H., Lamaziere, J.-M. D., Bonnet, J. (1999). Vascular Cell Adhesion Molecule-1 Gene Expression during Human Smooth Muscle Cell Differentiation Is Independent of NF-kappa B Activation. J. Biol. Chem. 274: 2308-2314 [Abstract] [Full Text]  
  • Satyaraj, E., Storb, U. (1998). Mef2 Proteins, Required for Muscle Differentiation, Bind an Essential Site in the Ig {lambda} Enhancer. J. Immunol. 161: 4795-4802 [Abstract] [Full Text]  
  • Lin, Q, Lu, J, Yanagisawa, H, Webb, R, Lyons, G., Richardson, J., Olson, E. (1998). Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125: 4565-4574 [Abstract]  
  • Wilson, E., Vives, F., Collins, T., Ives, H. E. (1998). Strain-Responsive Regions in the Platelet-Derived Growth Factor-A Gene Promoter. Hypertension 31: 170-175 [Abstract] [Full Text]  
  • Fisher, S., Siwik, E, Branellec, D, Walsh, K, Watanabe, M (1997). Forced expression of the homeodomain protein Gax inhibits cardiomyocyte proliferation and perturbs heart morphogenesis. Development 124: 4405-4413 [Abstract]  
  • Yu, Y.-T., Yu, Y. T. (1996). Distinct Domains of Myocyte Enhancer Binding Factor-2A Determining Nuclear Localization and Cell Type-specific Transcriptional Activity. J. Biol. Chem. 271: 24675-24683 [Abstract] [Full Text]  
  • Ornatsky, O. I., McDermott, J. C. (1996). MEF2 Protein Expression, DNA Binding Specificity and Complex Composition, and Transcriptional Activity in Muscle and Non-muscle Cells. J. Biol. Chem. 271: 24927-24933 [Abstract] [Full Text]  
  • Firulli, A. B., Miano, J. M., Bi, W., Johnson, A. D., Casscells, W., Olson, E. N., Schwarz, J. J. (1996). Myocyte Enhancer Binding Factor-2 Expression and Activity in Vascular Smooth Muscle Cells : Association With the Activated Phenotype. Circ. Res. 78: 196-204 [Abstract] [Full Text]  
  • Andrés, V., Cervera, M., Mahdavi, V. (1995). Determination of the Consensus Binding Site for MEF2 Expressed in Muscle and Brain Reveals Tissue-specific Sequence Constraints. J. Biol. Chem. 270: 23246-23249 [Abstract] [Full Text]  
  • Nagata, D., Suzuki, E., Nishimatsu, H., Satonaka, H., Goto, A., Omata, M., Hirata, Y. (2001). Transcriptional Activation of the cyclin D1 Gene Is Mediated by Multiple Cis-Elements, Including SP1 Sites and a cAMP-responsive Element in Vascular Endothelial Cells. J. Biol. Chem. 276: 662-669 [Abstract] [Full Text]  
  • Mora, S., Pessin, J. E. (2000). The MEF2A Isoform Is Required for Striated Muscle-specific Expression of the Insulin-responsive GLUT4 Glucose Transporter. J. Biol. Chem. 275: 16323-16328 [Abstract] [Full Text]